1. Home
  2. AMRX vs CLM Comparison

AMRX vs CLM Comparison

Compare AMRX & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • CLM
  • Stock Information
  • Founded
  • AMRX 2002
  • CLM 1987
  • Country
  • AMRX United States
  • CLM United States
  • Employees
  • AMRX N/A
  • CLM N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • CLM Finance/Investors Services
  • Sector
  • AMRX Health Care
  • CLM Finance
  • Exchange
  • AMRX Nasdaq
  • CLM Nasdaq
  • Market Cap
  • AMRX 2.5B
  • CLM 2.1B
  • IPO Year
  • AMRX N/A
  • CLM N/A
  • Fundamental
  • Price
  • AMRX $8.01
  • CLM $8.42
  • Analyst Decision
  • AMRX Strong Buy
  • CLM
  • Analyst Count
  • AMRX 5
  • CLM 0
  • Target Price
  • AMRX $10.00
  • CLM N/A
  • AVG Volume (30 Days)
  • AMRX 1.1M
  • CLM 1.4M
  • Earning Date
  • AMRX 11-08-2024
  • CLM 01-01-0001
  • Dividend Yield
  • AMRX N/A
  • CLM 18.74%
  • EPS Growth
  • AMRX N/A
  • CLM N/A
  • EPS
  • AMRX N/A
  • CLM N/A
  • Revenue
  • AMRX $2,680,420,000.00
  • CLM N/A
  • Revenue This Year
  • AMRX $17.86
  • CLM N/A
  • Revenue Next Year
  • AMRX $3.90
  • CLM N/A
  • P/E Ratio
  • AMRX N/A
  • CLM N/A
  • Revenue Growth
  • AMRX 12.32
  • CLM N/A
  • 52 Week Low
  • AMRX $5.01
  • CLM $6.25
  • 52 Week High
  • AMRX $9.48
  • CLM $8.84
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 42.36
  • CLM 41.67
  • Support Level
  • AMRX $7.68
  • CLM $8.22
  • Resistance Level
  • AMRX $8.18
  • CLM $8.80
  • Average True Range (ATR)
  • AMRX 0.29
  • CLM 0.22
  • MACD
  • AMRX -0.04
  • CLM -0.10
  • Stochastic Oscillator
  • AMRX 25.41
  • CLM 28.52

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.

Share on Social Networks: